9-(4'-aminophenyl)-9h-pyrido(3,4-b)indole has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamori, T; Kitamura, T; Shibata, H; Sugimura, T; Totsuka, Y; Uchiya, N; Wakabayashi, K | 1 |
| Kohno, H; Sugie, S; Suzuki, R; Tanaka, T; Totsuka, Y; Wakabayashi, K; Yasui, Y | 1 |
2 other study(ies) available for 9-(4'-aminophenyl)-9h-pyrido(3,4-b)indole and Adenocarcinoma
| Article | Year |
|---|---|
Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats.
Topics: Adenocarcinoma; Aniline Compounds; Animals; beta Catenin; Carbolines; Carcinoma, Hepatocellular; Colon; Colonic Neoplasms; Cytoskeletal Proteins; Female; Genes, APC; Genes, ras; Harmine; Indoles; Leukemia; Liver; Liver Neoplasms; Male; Mutagens; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Pyridines; Rats; Rats, Inbred F344; Thyroid Neoplasms; Trans-Activators | 2004 |
Tumor-initiating potency of a novel heterocyclic amine, aminophenylnorharman in mouse colonic carcinogenesis model.
Topics: Adenocarcinoma; Animals; beta Catenin; Carcinogens; Colonic Neoplasms; Disease Models, Animal; DNA Adducts; Dose-Response Relationship, Drug; Indoles; Male; Mice; Mice, Inbred ICR; Mutagens; Mutation; Pyridines | 2007 |